Log in to save to my catalogue

Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals

Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2580693628

Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals

About this item

Full title

Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals

Publisher

New York: Springer US

Journal title

Bulletin of experimental biology and medicine, 2021-09, Vol.171 (5), p.627-632

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
177
Lu (ZHER2-HSA-chelator-
177
Lu) or
212
Pb (ZHER2-HSA-chelator-
212
Pb). The objective was to evaluate
in vitro
the cytotoxic activity of the targeted radiopha...

Alternative Titles

Full title

Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2580693628

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2580693628

Other Identifiers

ISSN

0007-4888

E-ISSN

1573-8221

DOI

10.1007/s10517-021-05283-4

How to access this item